RxDoctor Payments Data

Payam Salehi

Vascular Surgery · Boston, MANPI 1578737532

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $25,072 of the $39,690 with a category attached, or 63.2%. 43 manufacturers reported payments, led by Endologix LLC at 37.7% of the total. 2025 is the largest year on record at $9,611, 2.2 times the $4,349 reported in 2019. Among vascular surgery clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,690in general payments, 2019–2025

Across 281 payments — averaging $141.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endologix LLC$15K
  • Bolton Medical Inc$7K
  • Philips North America LLC$3K
  • W. L. Gore & Associates, Inc.$2K
  • Silk Road Medical, Inc.$2K
  • Medtronic$1K
  • plus $8K from 37 others
$105,425in research payments, 2019–2025

Across 21 payments — averaging $5020.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bolton Medical Inc$105K
  • Inspiremd Ltd$725

What the payments were for

  • Consulting fees$13,34334%
  • Travel & lodging$1,1003%
  • Food & beverage$25,07263%
  • Other$1750%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,690 in reported general payments places this provider in the 90th percentile of 142 vascular surgery providers in Massachusetts.

See all vascular surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$275,528
Medicare patients
1,134
Services billed
2,140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol31$773
Atorvastatin Calcium20$526
ClopidogrelClopidogrel Bisulfate17$150

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →